Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN84968882Phase 4Completed
Phase 4, randomised trial of propofol in cardiac disease, coronary arteriosclerosis and aortic valve disease (AVD) (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Myocardial injury. Started Feb 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN84968882.